Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LIXT
? LB-100 can kill cancer cells
https://finance.yahoo.com/news/lixte-biotechnology-holdings-inc-reports-171600881.html
? 8k confirming https://sec.gov/ix?doc=/Archives/edgar/data/0001335105/000149315223004180/form8-k.htm
? Per company No known competitor to LB-100 in the market.
? Non stop insiders buys Form 4
? Cost to Borrow 140% ~ 296%
$LIXT
? LB-100 can kill cancer cells
https://finance.yahoo.com/news/lixte-biotechnology-holdings-inc-reports-171600881.html
? 8k confirming https://www.sec.gov/ix?doc=/Archives/edgar/data/0001335105/000149315223004180/form8-k.htm
? Per company No known competitor to LB-100 in the market.
? Non stop Insiders buys Form 4
? Cost to Borrow 140% ~ 296%
$APRN Insiders +778% Short Interest 43%
Turnaround story, candidate to go private or buyout target
A Blue Apron Holdings, Inc. (NYSE:APRN) insider increased their holdings by 778% last year
https://finance.yahoo.com/news/blue-apron-holdings-inc-nyse-134825587.html
$APRN Insiders +778% Short Interest 43%
Turnaround story, candidate to go private or buyout target
A Blue Apron Holdings, Inc. (NYSE:APRN) insider increased their holdings by 778% last year
https://finance.yahoo.com/news/blue-apron-holdings-inc-nyse-134825587.html
$BTB $2.27
?Bitcoin Mining stock
?Investigate Suspected Illegal Short
https://finance.yahoo.com/news/bit-brothers-board-directors-forms-144500576.html
?Offering closed $4.5
https://finance.yahoo.com/news/bit-brother-limited-closes-previously-180200526.html
*** Company will not issue Shares 60 days
*** Lock-Up Agreement 120 days
?Completed reverse split
?Book Value $12.46 (YFinance)
$BTB $2.27
?Bitcoin Mining stock
?Investigate Suspected Illegal Short
https://finance.yahoo.com/news/bit-brothers-board-directors-forms-144500576.html
?Offering closed $4.5
https://finance.yahoo.com/news/bit-brother-limited-closes-previously-180200526.html
*** Company will not issue Shares 60 days
*** Lock-Up Agreement 120 days
?Completed reverse split
?Book Value $12.46 (YFinance)
$BTB as of 6/30/2022
Total Revenue------------------------765.094M
Total Assets --------------------------114,575M
Total Liabilities Net Minority Interest--1,137M
Y Finance
$BTB as of 6/30/2022
Total Revenue------------------------765.094M
Total Assets --------------------------114,575M
Total Liabilities Net Minority Interest--1,137M
Y Finance
$BTB
?Bitcoin Mining stock
?Investigate Suspected Illegal Short
https://finance.yahoo.com/news/bit-brothers-board-directors-forms-144500576.html
?Offering close $4.5
https://finance.yahoo.com/news/bit-brother-limited-closes-previously-180200526.html
?Completed reverse split recently
$BTB
?Bitcoin Mining stock
?Investigate Suspected Illegal Short
https://finance.yahoo.com/news/bit-brothers-board-directors-forms-144500576.html
?Offering close $4.5
https://finance.yahoo.com/news/bit-brother-limited-closes-previously-180200526.html
?Completed reverse split recently
$NHMD 0004/ 0005
?One of the cheapest Bitcoin mining stock
?Pink Current Information
?< 600M float
?Partnership w/ ABCO labs revenues $15 M
?52 Week high 0.0040
?Active Twitter account https://twitter.com/natesfoodco
$NHMD 0004/ 0005
?One of the cheapest Bitcoin mining stock
?Pink Current Information
?< 600M float
?Partnership w/ ABCO labs revenues $15 M
?52 Week high 0.0040
?Active Twitter account https://twitter.com/natesfoodco
$NRBO Upcoming Catalyst per 10Q any day
*** Upcoming Catalyst, Phase 2 clinical trial of ANA001 for treatment of moderate COVID-19
analysis of the clinical trial data, which is expected in the fourth quarter of 2022.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1638287/000155837022017864/nrbo-20220930x10q.htm
*** New insider Goldman Sachs 1.2M
https://www.sec.gov/Archives/edgar/data/1638287/000120919122058402/xslF345X02/doc3.xml
*** Completed RS
https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-reverse-stock-131500951.html
*** Completed Offering $3
https://finance.yahoo.com/news/neurobo-announces-closing-32-3-210500773.html
*** Low Float, Price near bottom.
*** Short Interest ~14%, Cost to Borrow 235%
$NRBO Upcoming Catalyst per 10Q any day
*** Upcoming Catalyst, Phase 2 clinical trial of ANA001 for treatment of moderate COVID-19
analysis of the clinical trial data, which is expected in the fourth quarter of 2022.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1638287/000155837022017864/nrbo-20220930x10q.htm
*** New insider Goldman Sachs 1.2M
https://www.sec.gov/Archives/edgar/data/1638287/000120919122058402/xslF345X02/doc3.xml
*** Completed RS
https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-reverse-stock-131500951.html
*** Completed Offering $3
https://finance.yahoo.com/news/neurobo-announces-closing-32-3-210500773.html
*** Low Float, Price near bottom.
*** Short Interest ~14%, Cost to Borrow 235%
$APRN Top Gamma Squeeze and high Short Interest 57%
$APRN Top Gamma Squeeze and high Short Interest 57%
$ATNX Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer
https://finance.yahoo.com/news/athenex-announces-quantum-leap-healthcare-131500015.html
Multiple Form 4 October, November, and December
$ATNX Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer
https://finance.yahoo.com/news/athenex-announces-quantum-leap-healthcare-131500015.html
Multiple Form 4 October, November, and December
$APRN Candidate to go private or buyout target
also possible Short squeeze or Gamma squeeze
$APRN Candidate to go private or buyout target
also possible Short squeeze or Gamma squeeze
$APRN short interest 61% (S3 data)
News today: Mr. Sanberg has stated that he and his affiliates remain committed to funding the remaining purchase obligation of $55.5 million at $5.65 per share under the private placement agreement.
https://finance.yahoo.com/news/blue-apron-provides-sanberg-funding-140000293.html
$APRN Joe Sanberg owns 51.33%
https://www.sec.gov/Archives/edgar/data/1701114/000119312522240044/d399705dsc13da.htm
Major Holders
67.32%--% of Shares Held by All Insider
13.81%--% of Shares Held by Institutions
https://finance.yahoo.com/quote/APRN/holders?p=APRN
$APRN short interest 61% (S3 data)
News today: Mr. Sanberg has stated that he and his affiliates remain committed to funding the remaining purchase obligation of $55.5 million at $5.65 per share under the private placement agreement.
https://finance.yahoo.com/news/blue-apron-provides-sanberg-funding-140000293.html
$APRN Joe Sanberg owns 51.33%
https://www.sec.gov/Archives/edgar/data/1701114/000119312522240044/d399705dsc13da.htm
Major Holders
67.32%--% of Shares Held by All Insider
13.81%--% of Shares Held by Institutions
https://finance.yahoo.com/quote/APRN/holders?p=APRN
$PIK #1 Most shorted stock (S3 data)
? High Short Interest 104% (S3 data)
? High Cost to Borrow 128%
? Low Float 1M
? Price Target $7
? 86.36% Held by All Insider
$PIK #1 Most shorted stock (S3 data)
? High Short Interest 104% (S3 data)
? High Cost to Borrow 128%
? Low Float 1M
? Price Target $7
? 86.36% Held by All Insider
$PIK Short Interest 104%
$Pik Short Interest 104%
$PIK 76% Short Interest
#1 Top Shorted Stocks S3 data
Cost to Borrow 110%
Low Float 1M
#ShortSqueeze #wallstreetbets
$PIK 76% Short Interest
#1 Top Shorted Stocks S3 data
Cost to Borrow 110%
Low Float 1M
#ShortSqueeze #wallstreetbets